U.S Class(es): 006, 018, 044, 046, 051, 052
| Name | Novartis Pharma AG, |
|---|---|
| Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Oct-25-2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
| Oct-29-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
| Oct-30-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Nov-03-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Nov-13-2018 | ASSIGNED TO EXAMINER | DOCKD | |
| Nov-15-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Dec-05-2018 | NOTICE OF PUBLICATION | NPUBO | |
| Dec-25-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Mar-12-2019 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Apr-11-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| May-01-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
| May-01-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| Aug-16-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Feb-12-2024 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
| Feb-12-2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENCO |